NCT06209996 A Weight Management Intervention for Overweight Chinese Cancer Survivors
| NCT ID | NCT06209996 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Hong Kong |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 102 participants |
| Start Date | 2024-10-31 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 102 participants in total. It began in 2024-10-31 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to conduct a feasibility trial to examine the feasibility and acceptability of conducting a randomized controlled trial that evaluates the effect of the weight management intervention on anthropometric measures (body weight and BMI), dietary quality, physical activity levels, physical and psychosocial functioning, self- efficacy for weight loss and quality of life.
Eligibility Criteria
Inclusion Criteria: * Chinese cancer survivors attending the one-off face-to-face survivorship care clinic * who are Cantonese- or Mandarin- speaking * aged 18 or above * diagnosed with early-stage disease (stage 0-II) * have completed primary and adjuvant treatments such as chemotherapy and radiotherapy * and with a BMI ≥ 23 kg/m2, as indicative as overweight or obesity using Asia-Pacific BMI cutoffs at 3-months reassessment Exclusion Criteria: * Non-Chinese survivors with advanced or metastatic disease * who have communication difficulties, mobility impairment or cognitive disabilities
Contact & Investigator
Danielle Ng, PhD
PRINCIPAL INVESTIGATOR
School of Public Health, The University of Hong Kong
Frequently Asked Questions
Who can join the NCT06209996 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06209996 currently recruiting?
Yes, NCT06209996 is actively recruiting participants. Contact the research team at dwlng@hku.hk for enrollment information.
Where is the NCT06209996 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT06209996 clinical trial?
NCT06209996 is sponsored by The University of Hong Kong. The principal investigator is Danielle Ng, PhD at School of Public Health, The University of Hong Kong. The trial plans to enroll 102 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.